HIV drug Dolutegravir's impact on pregnancy weight under the microscope

This study followed about 1,900 pregnant women and their babies for two years to see how HIV and the medication dolutegravir affect weight gain and overall metabolic health. Researchers compared women with HIV to those without, and also looked at differences between women who started dolutegravir during pregnancy versus those who were already taking it. The goal was to understand the links between HIV treatment, obesity, and health outcomes for both mothers and children.